One of the world’s most highly-publicized cases of COVID-19 is now tied to an IP dispute, as Regeneron Pharmaceuticals, the company that developed the “antibody cocktail” used to treat Donald Trump, is facing a patent lawsuit. As reported by BNN Bloomberg, the dispute revolves around a fluorescent protein that Regeneron used in its development of the antibody treatment. California company Allele Biotechnology and Pharmaceuticals has alleged that Regeneron did not obtain proper authorization for its use of the protein and seeks royalties for its unauthorized use.
Allele was granted a patent for “mNeonGreen” in March 2019, which generally relates to the use of a fluorescent protein that is injected into cells so that researchers can see what is happening. In the case of COVID-19, it can be used in drugs to see how the virus reacts to an antibody.
Allele reportedly reached out to Regeneron to negotiate a licence to use its technology, but Regeneron reportedly did not answer the company’s requests. Allele stated that the protein has been referred to as the “gold standard” in antibody and vaccine testing by scientific journals, and hundreds of organizations have active licences to use the technology. The company has emphasized that its goal in the lawsuit is recognition for its role in this area of development and to maintain its patent rights.
As of June 1, 2026, the Trademarks Opposition Board (TMOB) requires all confidential evidence and documentation in proceedings under sections 11.13, 38, or 45 of the Trademarks Act (the “Act”) to be…
The sneaker company, 1587 Sneakers, is reportedly suing Kansas City Chiefs players, Patrick Mahomes and Travis Kelce, along with their restaurant partners, for trademark infringement.1587 Sneakers…
As reported by Bloomberg Law News, PEI Licensing (“PEI”), the owner of the Penguin apparel brand, has sued Pudgy Penguins NFT (“Pudgy Penguins”) for trademark infringement.Pudgy Penguins started as a…
Nike is reportedly attempting to revive its classic “Total 90” soccer cleat line, but has encountered an unexpected setback. Total90, LLC has reportedly asserted that Nike is infringing its…
As reported by Bloomberg, attempts to register marks covering the phrases “All Rise” and “Here Comes the Judge” were rejected by the U.S. Court of Appeals for the Federal Circuit. In…
The Federal Court of Appeal’s recent decision in Promotion in Motion, Inc. (PIM Brands, Inc.) v. Hershey Chocolate & Confectionery LLC offers fresh guidance on how courts evaluate survey evidence…
